<DOC>
	<DOCNO>NCT00364546</DOCNO>
	<brief_summary>The purpose study evaluate safety CG5503 base Immediate Release ( IR ) 50 mg 100 mg take every 4 6 hour need long-term exposure 90 day patient chronic pain .</brief_summary>
	<brief_title>A Study Evaluate 90-Day Safety Tapentadol ( CG5503 ) Immediate Release ( IR ) Oxycodone Immediate Release Patients With Chronic Pain</brief_title>
	<detailed_description>CG5503 centrally active pain-relieving drug investigate treatment acute chronic pain . This study design assess safety CG5503 Immediate Release ( IR ) men woman 18 year age old chronic ( least 3 month ) low-back pain chronic pain osteoarthritis hip knee , require daily analgesic medication . In double blind study ( neither patient investigator know treatment give ) , patient randomly ( patient assign different treatment base chance ) assign receive either CG5503 base IR oxycodone IR begin 90 day treatment patient return medical facility every 2 week . For CG5503 IR group , patient take 50 100 mg orally every 4 6 hour need maximum dose 600 mg per day . Oxycodone IR patient take 10 15 mg orally every 4 6 hour need maximum dose 90 mg per day . Patients may continue take regular , stable , non-opioid medication throughout study . The effectiveness study treatment ( CG5503 base IR oxycodone ) assess 11-Point Numerical Rating Scale Patient Global Impression Change . Using scale , patient indicate pain intensity level overall status well-being . Opioid withdrawal symptom CG5503 IR dose 50 100 mg assess clinical opioid withdrawal scale [ Subjective Opiate Withdrawal Scale ( SOWS ) Clinical Opiate Withdrawal Scale ( COWS ) ] end treatment . Using scale , patient indicate physical component drug withdrawal severity symptom associate rapid withdrawal . Safety assess use physical examination , monitor adverse event , clinical laboratory measure , 12 lead electrocardiogram ( ECG ) result . Constipation , vomit , sleep assessment perform . No formal hypothesis test do study . For CG5503 IR group , patient take flexible dose 50 100 mg orally every 4 6 hour need maximum dose 600 mg per day 90 day . Oxycodone IR patient take flexible dose 10 15 mg orally every 4 6 hour need maximum dose 90 mg per day 90 day .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Sciatica</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>A clinical diagnosis one following : lowback pain nonmalignant origin least 3 month , osteoarthritis knee hip least 3 month require daily dos analgesia medication chronic pain consistent make candidate treatment Step 2 high WHO Pain Relief Ladder postwashout baseline pain intensity score &gt; 4 11point numerical rating scale History seizure disorder epilepsy uncontrolled hypertension currently treat monoamine oxidase inhibitor systemic steroid therapy , exclude inhaler topical steroid , within 3 month screen history malignancy within past 2 year , exception basal cell carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Low Back Pain</keyword>
	<keyword>Hip Pain</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Backache</keyword>
	<keyword>tapentadol</keyword>
</DOC>